🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947
This research study is being done to compare the effects of Aprepitant and ...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2017-01-27
Trial ID
NCT02989467
Treatments Being Tested
Title of the study Aprepitant for prevention of acute and delayed nausea an...
Status
Unknown
Location
Azienda Ospedaliera di Perugia - Hematology dept.
Start Date
2010-04
Trial ID
NCT01088022
Treatments Being Tested
This study will compare the safety and efficacy of a three-day oral aprepit...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-13
Trial ID
NCT01362530
Delayed nausea is a common problem after high dose chemotherapy for bone ma...
Status
Completed
Location
Uppsala University Hospital
Start Date
2010-05
Trial ID
NCT01101529
Treatments Being Tested
The purpose of this study is to find out whether or not adding aprepitant(E...
Status
Completed
Location
Jimmy Everest Center for Cancer and Blood Disorders in Children
Start Date
2012-06-01
Trial ID
NCT01661335
Treatments Being Tested
This randomized phase III trial studies antiemetic therapy with olanzapine ...
Status
Completed
Location
Anchorage Associates in Radiation Medicine
Start Date
2014-08-20
Trial ID
NCT02116530
RATIONALE: Antiemetic drugs, such as aprepitant, ondansetron, and dexametha...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2004-05
Trial ID
NCT00248547
Treatments Being Tested
Aprepitant and olanzapine have been recommended for emesis prevention from ...
Status
Unknown
Location
Division of medical oncology, department of medicine Siriraj Hospital
Start Date
2019-03-01
Trial ID
NCT03876938
Treatments Being Tested
The study will test aprepitant for the prevention of CINV in patients recei...
Status
Completed
Location
Multiple Locations
Start Date
2007-01-01
Trial ID
NCT00337727